患者死亡风险和不良反应在Liothyronine:一个多来源的系统审查和元分析
Suhani Bahl1, Peter N Taylor1, Lakdasa D Premawardhana1
1Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, Wales, UK.
The Journal of clinical endocrinology and metabolism
|August 12, 2025
概括
针对甲状腺功能低下症的调节型甲氨酸 (LT3) 与利沃甲氧氨酸 (LT4) 联合治疗是安全的,没有增加不良事件或死亡风险. 建议进行进一步的研究,以补充目前的发现.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 患者更喜欢使用利奥氨酸 (LT3) 和利沃氨酸 (LT4) 治疗甲状腺功能低下的组合疗法.
- 特别是在组合治疗中,LT3的安全性需要彻底调查.
研究的目的:
- 进行全面的系统审查和元分析,评估LT3的安全性.
- 评估与LT3使用相关的不良事件,心血管结果和死亡率.
主要方法:
- 在PubMed,英国黄卡计划和美国FDA不良报告系统 (FAERS) 的系统文献搜索.
- 包括52项研究:21个随机对照试验 (RCT),4个队列研究和27个病例报告.
- 对来自RCT和队列研究的不良结果进行的元分析,比较组合LT3/LT4治疗与LT4单一治疗.
主要成果:
- 与LT3相关的不良事件 (AEs) 主要与不受管制的使用或复合错误有关.
- 对FAERS和黄卡计划的分析显示,与LT4相比,LT3的安全信号没有增加,AE严重程度也没有显著差异.
- 对RCT的分析显示,组合治疗和单一治疗之间存在类似的AE风险 (RR 1.22).
- 队列元分析 (n=630,254) 显示,心房动,心力衰竭或中风风险没有增加,但LT3的死亡风险降低 (RR 0.70).
结论:
- 定期使用LT3并没有增加死亡或严重不良结果的风险.
- 这些发现支持LT3在甲状腺功能低下症组合治疗中的安全性.
- 需要进行额外的研究来进一步证实这些安全数据.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Functions of Thyroid Hormones
3.2K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
977
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
977
Therapeutic Index
5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K


